Clinical trial
Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell…
NCT00336206 · Tawam Hospital, Other · Unknown status
Key facts
| NCT number | NCT00336206 |
|---|---|
| Title | Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia |
| Official title | Subcutaneous Injection, Low Dose Alemtuzumab for Consolidation and Maintenance of Patients in Clinical Response After Having Achieved Partial or Complete Remission After 1st or 2nd Line Anti-Tumor Therapy for B-Cell CLL |
| Lead sponsor | Tawam Hospital, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | B-Cell Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Alemtuzumab |
| Enrollment | 60 |
| Start date | Jul 1, 2006 |
| Completion | Oct 1, 2009 |
| First posted | Jun 13, 2006 |
| Last update posted | Jul 25, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: